Literature DB >> 26817906

Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.

Meizhu Xiao1, Qiuxiang Xu, Hongyan Li, Huiqiao Gao, Yachun Bie, Zhenyu Zhang.   

Abstract

The aim of the study is to investigate the prevalence of high-risk human papillomavirus (hr-HPV) genotypes among Han women with high-grade cervical lesions in Beijing, China.Cervical cell specimens from patients with histopathologically confirmed cervical lesions at 7 hospitals in Beijing were examined with a validated HPV kit for 13 hr-HPV genotypes during the study period. The patients were divided into a low-grade cervical lesions group (cervical intraepithelial neoplasia grade 1, CIN1) and a high-grade cervical lesions group (CIN2+, including cervical intraepithelial neoplasia grade 2, CIN2; cervical intraepithelial neoplasia grade 3, CIN3; squamous cervical cancer, SCC; and adenocarcinoma of the cervix, ACC) based on the histopathology results.A total of 2817 eligible patients were enrolled, including 610 cases identified as CIN1 and 2207 as CIN2+. The hr-HPV positive rates in the CIN1 and CIN2+ groups were 78.2% (477/610) and 93.3% (2060/2207), respectively. The most frequently detected genotypes were HPV16, 58, 52 and18 in the CIN1 group and HPV16, 58, 33, and 52 in the CIN2+ group, in descending order of prevalence. In addition, the prevalence of HPV18 among the patients with ACC was 28.6% (14/49), significantly >7.2% (54/752) prevalence among the SCC patients (P < 0.001). Additionally, significantly more women in the CIN2+ group had multiple infections compared with those in the CIN1 group (38.1% and 24.9%, respectively; P < 0.001). However, as the cervical lesion grade increased, the prevalence of multiple hr-HPV infections gradually deceased to 44.2% in the CIN2 patients, 36.7% in the CIN3 patients, and 35.3% in the cervical cancer (CC) patients, which included SCC and ACC patients. In cases of multiple hr-HPV infections in the CIN2+ group, double infections accounted for ∼76.6%, and HPV16+58, HPV16+52, and HPV16+18 were the most common combinations, in descending order. The most frequent combination for triple infections was HPV16+58+31, with a rate of 4.2%. The highest positive rate occurred in the ≤24 year-old group for all types of cervical lesions.The prevalence of HPV genotypes in the targeted population with high-grade cervical lesions differs from that of other countries. This information could be helpful for the prevention of CC in Beijing, China.

Entities:  

Mesh:

Year:  2016        PMID: 26817906      PMCID: PMC4998280          DOI: 10.1097/MD.0000000000002555

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  39 in total

1.  Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.

Authors:  Wen Chen; Xun Zhang; Anco Molijn; David Jenkins; Ju-Fang Shi; Wim Quint; Johannes E Schmidt; Ping Wang; Yu-Ling Liu; Lian-Kun Li; Hong Shi; Ji-Hong Liu; Xing Xie; Mayinuer Niyazi; Pei Yang; Li-Hui Wei; Long-Yu Li; Jie Li; Jin-Feng Liu; Qi Zhou; Ying Hong; Li Li; Qing Li; Hong-Lin Zhou; Mei-Lu Bian; Jing Chen; You-Lin Qiao; Jennifer S Smith
Journal:  Cancer Causes Control       Date:  2009-08-25       Impact factor: 2.506

2.  The ATHENA human papillomavirus study: design, methods, and baseline results.

Authors:  Thomas C Wright; Mark H Stoler; Catherine M Behrens; Raymond Apple; Toniann Derion; Teresa L Wright
Journal:  Am J Obstet Gynecol       Date:  2011-07-22       Impact factor: 8.661

Review 3.  Natural history of cervical intraepithelial neoplasia: a critical review.

Authors:  A G Ostör
Journal:  Int J Gynecol Pathol       Date:  1993-04       Impact factor: 2.762

4.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

5.  Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.

Authors:  Lucia Rössler; Olaf Reich; Reinhard Horvat; Sabrina Collas de Souza; Katsyarina Holl; Elmar A Joura
Journal:  Wien Klin Wochenschr       Date:  2013-09-17       Impact factor: 1.704

6.  Prevalence of human papillomavirus in cervical cancer: a multicenter study in China.

Authors:  Keith W K Lo; Y F Wong; May K M Chan; James C B Li; J S Poon; Vivian W Wang; S N Zhu; T M Zhang; Z G He; Q L Wu; G D Li; John S L Tam; T Kahn; P Lam; T H Cheung; Tony K H Chung
Journal:  Int J Cancer       Date:  2002-07-20       Impact factor: 7.396

7.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

8.  Multiple HPV infection in cervical cancer screened by HPVDNAChip.

Authors:  Sang Ah Lee; Daehee Kang; Sang Soo Seo; Jeongmi Kim Jeong; Keun Young Yoo; Yong Tark Jeon; Jae Weon Kim; Noh Hyun Park; Soon Beom Kang; Hyo Pyo Lee; Yong Sang Song
Journal:  Cancer Lett       Date:  2003-08-20       Impact factor: 8.679

9.  Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients.

Authors:  Ying Li; Yipeng Wang; Chanwei Jia; Yanmin Ma; Yonglian Lan; Shuyu Wang
Journal:  Cancer Genet Cytogenet       Date:  2008-04-01

10.  Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.

Authors:  Jack Cuzick; Linda Ho; George Terry; Michelle Kleeman; Michael Giddings; Janet Austin; Louise Cadman; Lesley Ashdown-Barr; Maria J Costa; Anne Szarewski
Journal:  J Clin Virol       Date:  2014-02-14       Impact factor: 3.168

View more
  5 in total

1.  Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.

Authors:  Jin Zhao; Zhong Guo; Qiang Wang; Tianbin Si; Shuyan Pei; Chenjing Wang; Hongmei Qu; Jianbin Zhong; Ying Ma; Cong Nie; Dan Zhang
Journal:  Infect Agent Cancer       Date:  2017-01-25       Impact factor: 2.965

2.  Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China.

Authors:  Kemin Li; Rutie Yin; Danqing Wang; Qingli Li
Journal:  Oncotarget       Date:  2017-04-25

3.  Correlation between Human Papillomavirus Codetection Profiles and Cervical Intraepithelial Neoplasia in Japanese Women.

Authors:  Kaori Okayama; Hirokazu Kimura; Koji Teruya; Yasuyoshi Ishii; Kiyotaka Fujita; Masahiko Fujii; Mizue Oda; Toshiyuki Sasagawa; Mitsuaki Okodo
Journal:  Microorganisms       Date:  2020-11-25

4.  S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.

Authors:  Aifang Li; Yue Gu; Xueru Li; Hui Sun; He Zha; Jiaqing Xie; Jiali Zhao; Mao Huang; Lu Chen; Qi Peng; Yan Zhang; Yaguang Weng; Lan Zhou
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

5.  Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.

Authors:  Hui-Hui Xu; Kai Wang; Xing-Jun Feng; Shan-Shan Dong; Aifen Lin; Ling-Zhi Zheng; Wei-Hua Yan
Journal:  Oncotarget       Date:  2018-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.